We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Yumbles is a leading UK online marketplace for artisan food. It currently connects over 600 independent food makers directly with consumers. The company is targeting the UK’s estimated £10bn+ UK Speciality Food & Drink market, having seen £1m+ sales in the last 12 months resulting in £400k+ revenue.
days to go: Expired investment: £262,080
White Rabbit (WR) is on a mission to create delicious Italian food that everyone can enjoy, whether they are following a plant-based diet, gluten-free, or otherwise. WR asserts that its food is made in a custom-built bakery, designed from scratch by its Italian maestro Teo, who creates all of WR's recipes and handpicks every supplier. The company's products are stocked in retails outlets such as Sainsbury's, Waitrose, and Ocado's, to name a few. Independent sellers such as Whole Foods, Planet Organic and Selfridges are also among WR's clientele. The company has earned £2.4 million in revenue in the financial year 2020-2021 and is experiencing a 157% average year on year revenue growth. WR will use the investment to support the development and launch of Teo's new products, grow its commercial and operations teams, and expand its frozen storage capacity.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £513,193
Redchurch Brewery have previously successfully raised on Crowdcube, expanding with a 30 barrel brew house in Harlow and rebranding, which secured listings in Waitrose and M&S. With their next raise they will be looking to invest in faster packaging, increasing staff and delivery vehicles, and adding further fermentation vessels to increase production to more than 1.3 million litres annually which is around 2.3 million pints of beer.
days to go: Expired investment: £395,760
An array of nine acclaimed cafés situated in central London providing nutritional brunches and dinners with craft beers and cocktails. Daisy Green have flourished in the antipodean café sector due to their authentic offerings, which focus on sustainably sourcing ingredients without compromising on quality and value.
days to go: Expired investment: £1,994,700
Social Republic is a dining club that is run for the people, by the people. Social Republic helps supper clubs join together. It does this by allowing any member to be an organiser or a host. This means they can run just a single event or a whole supper club. Either way they are not tied to a schedule. 
days to go: Expired investment: £359
Five Points Brewing Company are an independent craft brewery.  Since the company started in 2013, the demand has risen beyond capacity and they are looking for investment to treble the capacity of their brewery and open a Tap Room on the five point’s junction they are named after.
days to go: Expired investment: £1,141,840
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph